EazeBio is not a diagnostics company. We are a digital health and biological intelligence platform designed to help individuals and clinicians understand invisible biologic change earlier, continuously, and in context.Diagnostics are one input. Biological understanding over time is the product.
Most healthcare systems still rely on
By the time something appears “abnormal,” the underlying biological stress has often been present for months or years.
What's missing is the ability to see patterns, not just results.
This allows invisible biological change to be:
EazeBio supports multiple sensing modalities designed for different settings:
Simple and accessible tests with reader app for at-home use.
Higher-rigor assays paired with a dedicated reader for clinical and laboratory workflows.
High-sensitivity continuous sensing technologies designed to capture functional biology, not just static values.
Each modality feeds into the same interpretive framework.
Stress is one of the most powerful forces shaping human biology — yet it is often measured in static, indirect ways that miss how the body actually responds over time.
In parallel with our current wellness and clinical offerings, EazeBio is developing next-generation cortisol sensing technology based on advanced biosensing intellectual property we have acquired and are further developing through academic collaboration.
This work is designed to move beyond single, isolated measurements and toward a more functional, longitudinal understanding of stress biology — capturing how stress signals change over time and interact with sleep, metabolism, hormones, and recovery .
This capability reflects where the EazeBio platform is going:
from isolated tests to
continuous biological intelligence
.
This technology is under development and is not yet commercially available.
Individuals use simple tests with their smartphone acting as the reader and interpretation Intelligence, supporting wellness awareness and self-care.
Clinicians and partners use FIA-based workflows with a dedicated reader, enabling higher reproducibility, throughput, and professional review
In parallel, EazeBio is developing next-generation cortisol sensing technology based on biosensing IP we have acquired and are co-developing with University of California, Santa Cruz.
This work reflects where the platform is going — not just where it is today.
The EazeBio platform aligns with emerging healthcare models
"It is designed to augment clinical reasoning, not replace it."
EazeBio maintains clear separation between use cases:
are positioned as wellness screening tools
are designed for clinical and laboratory environments
varies by product and geography
by intent, interpretation, and context
EazeBio is building infrastructure for biological understanding — a system where biology is not a moment, but a journey
Diagnostics are one input — understanding biology over time is the outcome.
